Structure Therapeutics, Inc. (GPCR)

35.93 -0.09 (-0.25%) USD  |  NASDAQ  |  Sep 25, 16:00
35.90 -0.03 (-0.08%) After-Hours: 19:59
More

Structure Therapeutics Cash and Short Term Investments (Annual) : 1.446B for Dec. 31, 2025

Cash and Short Term Investments (Annual) Chart

View Cash and Short Term Investments (Annual) for GPCR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Short Term Investments (Annual) Chart
Start Trial

Historical Cash and Short Term Investments (Annual) Data

View and export this data back to 2020. Start Trial.
Date Value
December 31, 2025 1.446B
December 31, 2024 883.52M
December 31, 2023 467.32M
Date Value
December 31, 2022 90.84M
December 31, 2021 107.30M
December 31, 2020 37.44M

Cash and Short Term Investments Definition

Represents the sum of cash and short term investments.

Read full definition.

Cash and Short Term Investments (Annual) Range, Past 5 Years

View Cash and Short Term Investments (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Annual) Benchmarks

View Cash and Short Term Investments (Annual) Benchmarks
Start Trial
Eli Lilly & Co. 7.268B
Novo Nordisk A/S 4.240B
Pfizer Inc. 13.60B
Viking Therapeutics, Inc. 705.74M
Johnson & Johnson 20.10B